NCT06209281View on ClinicalTrials.gov

A Phase III Clinical Study of the Efficacy and Safety of Two Low-concentration Atropine Sulfate Eye Drops

PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

526

Participants

Timeline

Start Date

May 13, 2022

Primary Completion Date

August 20, 2023

Study Completion Date

December 31, 2025

Conditions
Myopia
Interventions
DRUG

Lower dose atropine sulfate eye drops

Administer to eyes

DRUG

Low dose atropine sulfate eye drops

Administer to eyes

DRUG

placebo

Administer to eyes

Trial Locations (1)

Unknown

Eye & ENT Hospital of Fudan University, Shanghai

All Listed Sponsors
lead

Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd.

INDUSTRY